FACT SHEET - S22.q4cdn

Transcription

FACT SHEETStryker Corporation2825 Airview BoulevardKalamazoo, Michigan 49002269 385 2600INVESTOR CONTACTKatherine A. OwenVice President, Strategy and Investor Relationskatherine.owen@stryker.com269 385 2600MISSION:TOGETHER WITH OUR CUSTOMERS,WE ARE DRIVENTO MAKE HEALTHCARE BETTER.Stryker is one of the world’s leading medical technologycompanies and together with our customers, we are drivento make healthcare better. The Company offers a diversearray of innovative products and services in Orthopaedics,Medical and Surgical, and Neurotechnology and Spine,which help improve patient and hospital outcomes. Stryker isactive in over 100 countries around the world.Charles DeCoster IV, MSAAssoc. Manager, Investor Relations and Strategycharles.decoster@stryker.com269 389 7421MEDIA CONTACTYin C. BeckerVice President, Communications, PublicAffairs and Strategic Marketingyin.becker@stryker.com201 831 5000AUGUST 2015

100 AT A GLANCEcountries whereStryker productsare sold2014 GEOGRAPHIC SALESORGANIC REVENUE States:24%2.6%2.4%68% 9.7B2.8%EmergingMarkets:201335straight years ofsales growth8%201222014StrykerMedTech Market 2ADJUSTED DILUTED NETEARNINGS PER SHARE 3CAPITAL ALLOCATION2012-2014 Capital Deployment History 4.73 4.49ShareRepurchases: 0.5BM & A: 3.4B 4.30Focused ondriving salesgrowth in coreand adjacentmarketsContinued sharebuybacksover time20122013ADJUSTED RETURN ON INVESTED CAPITAL 417.2% 201216.0% 2013patents ownedglobally in 201426,000 Dividends: 1.2BCommitted to increasingthe dividend at orabove EPS growth5,300 15.5% 20141 Organic revenue growth removes the impact of changes in foreign currency exchange rates and the first twelve months of acquisition salesthat affect the comparability and trend of sales.2 Data Source: Company analysis of 20 peer companies.3 Non-GAAP financial measure. These measures exclude intangible amortization from earnings in all periods (reference the reconciliation ofGAAP to non-GAAP in the Financial Summary).4 Return on Invested Capital: adjusted net earnings less interest expenses net of tax / (average total debt and total equity)2014employees worldwide

STRYKER ADVANTAGELEADING PLAYER IN MEDTECHStryker is a broadly diversified medical technology company with no single business inany segment representing more than 16 percent of total Stryker revenue. This balanceddiversity provides steady growth and enables the Company to pursue market opportunitiesin many promising areas.SUSTAINABILITY SOLUTIONS: 2%SPINE: 8%MEDICAL: 8%NEUROVASCULAR: 5%ENDOSCOPY: 14%NEURO POWERED INSTRUMENTS: 3%INSTRUMENTS: 15%CRANIOMAXILLOFACIAL: 2%2014SALESOTHER: 3%TRAUMA & EXTREMITIES: 13%STRENGTH IN KEY HOSPITALSERVICE LINESStryker’s broad product and service portfolio spansthree key hospital service lines: orthopaedics, neuroand specialty surgery. Stryker offers technologiesincluding operating room infrastructure andcommunications, equipment to perform surgeryeffectively and implants that help improve the qualityof patients’ lives. Stryker services are focused onpartnering with hospitals and physicians to helpdeliver proven quality outcomes and sustainableprofitability. This diverse array of innovative medicaltechnologies, combined with a continued focus on thecustomer through dedicated businesses structuredaround physician specialties, positions Stryker as aleading, preferred business partner in today’s changinghealthcare environment.HIPS: 13%Stryker has a significant opportunity to grow international market share through all ofits current business offerings. Stryker will accomplish this by leveraging its broad productportfolio and services, by continuing to capture market share in key developed marketsand building scale in emerging markets.Stryker is committed to growing its presence in emerging markets with emphasis onBrazil, Russia, India, China and Turkey as key growth areas through a two-prongedapproach of growing share in the premium market segment as well as expanding into thelower-priced market segment through the Trauson brand of technologies.FOCUSED ON INNOVATIONStryker’s relentless focus on innovationremains a cornerstone of its success, driven bythe Company’s enduring collaboration withhospitals and healthcare providers, whichensures that Stryker meaningfully understandstheir practice environment, treatment protocolsand unmet needs. This enables the Company tocontinue to consistently develop and market arange of life-enhancing and lifesaving productsthat help drive improved outcomes as well ascost savings and efficiencies.Stryker is also building upon its productdevelopment strength by broadening theCompany’s lens of innovation to includeprocedural solutions that help improve thepatient and customer experience. 10%KNEES: 14%ACCELERATING GLOBAL GROWTH33 YR CAGRR&DOPPORTUNITIES TO DRIVEMEANINGFUL OPERATINGLEVERAGEStryker sees significant opportunities to drivemeaningful operating leverage through its ongoingGlobal Quality and Operations initiatives, expansionof shared services, streamlining of informationtechnology systems and the establishment of itsEuropean regional headquarters, which will drive costsavings while enhancing the company’scustomer experience.BALANCE SHEET STRENGTHStryker’s operational cash flow generationdrives its strong balance sheet. That strengthallows the Company to make strategicacquisitions, which contribute to meetingthe commitment to delivering organic salesgrowth at the high end of MedTech, whilealso enabling increases in its dividend eachyear and share repurchases. With a solid netcash position, Stryker continues to optimizeits capital allocation to help enhance longterm shareholder value.

ST R AU M A & E XSTREEEMKNITIEEROTHORTHOPAEDICS43% OF TOTAL COMPANY SALESSALES 4.2BFinancial and market information reflects 2014 resultsOTHER RECONSTRUCTIVEROBOTIC etShare 5.9B#322%Stryker offers a comprehensiveportfolio of solutions forprimary, revision and partial hiparthroplasty. The Hip businesscontinues to drive the evolutionof clinically successful brandsincluding Accolade, Exeter andX3. Stryker utilizes SOMA, aproprietary analytics system todesign and validate implants foroptimized fit and performance.Its implant and instrumentplatforms are designed toaccommodate the wide varietyof surgical approaches used intoday’s evolving industry.Accolade IIThe first MorphometricWedge Stem which alsoaccommodates varioussurgical approaches,including direct anterior.Designed using SOMAto meet today’s patientpopulation.TRAUMA& EXTREMITIESH izeMarketPositionMarketShare 7.3B#319% 7.4B#217%Stryker offers a completeportfolio of implants and systemsdesigned to provide surgeonswith multiple options to treatpatients with osteoarthritis.Since its launch in 2009, theTriathlon single-radius designhas helped restore function andrelieve pain for over 1 millionpatients. Its single-radius kneesare designed to work with thebody to promote a natural-likecircular motion. The Company’sTriathlon Primary and RevisionKnee implants and instrumentsallow orthopaedic surgeons tomeet any situation that may ariseduring complex knee surgeries.Triathlon TritaniumCementless KneeThe Triathlon TritaniumCementless base plate andpatella offer the kinematicsof Triathlon coupled with thelatest in highly porous biologic3D fixation technology.14Stryker is a leading supplier of trauma and extremities productsfor the surgical treatment of bone fractures, abnormalities anddiseases. The Company’s portfolio consists of intramedullarynails, screws, external fixation, orthobiologics and plating. Itscommitment to innovation, dedication and education benefitsorthopaedic trauma surgery by helping surgeons to improvesurgical treatment and serve individual patient needs.FOOT & ANKLEMarketSizeMarketPositionMarketShare 1.3B#117%Stryker is dedicated to providing innovative product solutionsand outstanding service to the foot & ankle surgeon communityworldwide. Its comprehensive portfolio includes plating, externalfixation, nailing, screws and Memometal nitinol products. TheCompany is committed to improving patients’ lives by partneringwith surgeons to drive innovation, education and research.Triathlon Single-UseInstrumentsThe Single-Use Instrumentscompliments the Triathlon KneeSystem by eliminating the needfor up to 73% of non-essentialreusable instrumentation1traditionally used during a case.Precision Instrument Weight Analysis, TechnicalMemo to DHF 0930, June 17, 2011.MAKOplastyThe robotic arm assistedsurgery technology enables 3Dpre-operative planning andprovides surgeons with intraoperative tactile guidance forbone preparation and implantplacement.PERFORMANCESOLUTIONSThe MAKO platform bringsvalue to orthopaedicsurgery through proceduraladvancements, an improvedpatient experience focused onclinical outcomes and enhancedpatient satisfaction. MAKOrobotic arm assisted technologyopens the door for futureimplant innovations, enablingnew designs through robotic armcapabilities and functionality.Stryker Performance Solutionspartners with hospitals andphysician groups to createexceptional patient experiences,proven quality outcomesand sustainable profitability.It provides customers theperformance intelligencethey need to understand andbenchmark their orthopaedicservices and physician practices.With this intelligence thebusiness helps them plan forBONE CEMENTalignment strategies that willWith over 50 years of clinicalenable them to turn reformhistory, more than 600 published into opportunity and buildstudies and currently the topcustomized implementationselling bone cement in theprograms that help deliverworld,2 the Simplex family ofpatient-centric care andbone cements continue toquality outcomes.provide clinically-backed fixation.Global Markets for Bone Cement and Accessories 2012 - US, Europe (France, Germany,Italy, UK), Japan, Brazil, India, China. Millennium Research Group, December 2011.2Hoffmann (LRF) LimbReconstruction FrameA modern circular fixationsystem designed to reduceconstruct complexity andsimplify application addsnew versatility to matchtoday’s biological repair andreconstruction methods.ReUnion (RSA) ReverseShoulderThe ReUnion RSA is fullyintegrated and compatiblewith its existing primary totalshoulder platform featuringX3, 3D porous metal fixation,SmartLock and novel,streamlined instrumentation.STAR AnkleThe STAR ankle isthe only FDA PMAapproved cementless,mobile-bearing totalankle replacementsystem.

SUSOSTALU I NTMarketSizeMarketPositionMarketShare 5.6B#214%MarketShare 3.5B#141%Stryker is a leader in creatingproducts that make surgerymore efficient, reduce traumaand improve techniques. TheCompany is known for a widerange of innovative operatingroom products, from leadingsurgical power tools to personalprotection and waste/fluidmanagement. Stryker’s goalis to improve the surgical andpatient experience by developingproducts that are more reliablergand less complicatedto use.sudmeStryker also provides computerassisted surgery technologythat focuses on proceduralsimplification and workflowflexibility, and enables surgeonsto accurately track, analyze andmonitor instrumentation relativeto a patient’s anatomy duringsurgical procedures to enhanceuropatient outcomes.neNAV3iThe new NAV3i is StrykerNavigation’s next-generationplatform solution. TheNAV3i sleek design andpowerful computer offersthe surgeon enhancedvisualization and confidence.Stryker partners with healthcareproviders to help developa prevention strategy toimprove clinical and financialoutcomes, targeting key areasthat include patient falls,pressure ulcers, ventilatorassociated pneumonia andcaregiver injury. The Companyoffers a broad portfolio ofhospital beds and stretchers,pressure ulcer managementsolutions, connected hospitaltechnologies, hospital roomfurniture and temperaturemanagement solutions that setnew standards for a successfulpatient experience and empowerits customers by simplifyinghealthcare delivery throughsafety and efficiency. Its EMSline of powered and nonpowered ambulance cots, stairchairs, incubator transport,bariatric cots and ancillaryequipment delivers ease-of-use,durability and high return oninvestment.Reprocessed HarmonicACE ScalpelReprocessed-directedenergy device, originallymanufactured by EthiconEndo-Surgery, providesfinancial and environmentalsavings to hospitals.UMEN D O SC OMEDSURGFinancial and market information reflects 2014 resultsENDOSCOPYPYSPORTS MarketPositionMarketShare#154% 0.4BStryker is the leadingprovider of reprocessing andremanufacturing services forsingle-use medical devices.Stryker’s programs enablehealthcare organizations toreclaim and redirect financialresources toward initiatives thatcan increase the quality ofpatient care.IsolibriumIsolibrium is a poweredsupport surface designed toassist in the prevention andtreatment of all pressureulcers and isolates pressureredistribution through itsexclusive air pod technology.539% OF TOTAL COMPANY SALESSALES 3.8BM E D I CA ENeTYIL I eMarketPositionMarketShare 3.4B#125% 3.5B#48%As the technology leader in minimallyinvasive surgery, Stryker offers comprehensivesolutions to meet the changing needs of thehigh-tech operating room. It combines voiceactivation, infrared imaging and high-definitionvideo technology with a market leadingdata management system to offer a surgicalenvironment designed to improvepatient outcomes.Stryker offers a wide range of innovativesports medicine implants, instrumentationand biologic solutions. Its solutions focus onminimally invasive and open approaches tothe knee, shoulder, hip and small joints. TheCompany’s flexible technology helps optimizesurgical approaches and its all-suture anchorplatform minimizes bony removal during softtissue repair.COMMUNICATIONS*Today’s complex and technologically-advanced operating roomsfeature multiple video sources such as high definition endoscopiccameras, imaging modalities, X-ray and anesthesia data, all 1.4B#219%in varying video formats. Organizing this data, in addition toproviding consultative operating room design featuring Stryker’s LED surgical lights and equipmentbooms, allows Stryker to seamlessly integrate the operating room. Stryker is also focused ondelivering tele-presence solutions along with managing archived images and videos, and linkingthese digital assets to Electronic Medical Record systems. *Market share/position includes Berchtold acquisitionMarketSizeNeptune Waste ManagementSystemMarket-leading wastemanagement system providesimproved OR efficiency andprotection to both the patientand caregiver from hazardousfluid aMediatOR is a softwareThis device has enabled anplatform designed to facilitateimproved surgical experiencethe interoperability of Hospital through HD video capture, HISInformation Systems with integration and device managementmedical devices.that expands sterile field controland streamlines OR setup,leading to increased consistencyand personalization.ICONIXICONIX is an all-sutureanchor system used to repairsoft tissue sports injuriesthroughout the body andincludes a proprietary curveddelivery system that facilitatesanatomic placement acrossmultiple indications.

SPN EU R O P OI N ST R U W E RMEN T EDSMIO AN ACIALCRILLOFXAIN ESALES 1.7BNEUROTECHNOLOGY & SPINE18% OF TOTAL COMPANY SALESNEURO SizeMarketPosition6MarketShare 1.5B#133%Stryker is focused on advancingthe practice of less invasive stroketherapies through its CompleteStroke Care solutions. Stryker isdedicated to providing innovativestroke products and services forischemic and hemorrhagic stroke,and committed to providingclinical education and supportto help physicians deliver betterpatient outcomes. Products include:stent retriever, detachable coils,stents, balloons, guidewires andmicrocatheters.Target CoilsTrevo XP ProVue RetrieverTarget Coils are the globalTrevo XP ProVue Retrievermarket leader in aneurysmis the market-leading fullycoiling solutions. The Targetvisible stent retriever forproduct line consists ofremoving clots in patientsmultiple market-leadingexperiencing ischemic stroke.families, all of which provide The device provides a new levelsuperior coil delivery andof procedural simplicity forcatheter stability as compared their customers by giving themto competition. Strykerunprecedented informationcurrently provides theabout how the clot issmallest and softest coil oninteracting with the device.the market.MarketSizeMarketPositionMarketShare 1.2B#223%Stryker offers products for thespecific needs of Neurosurgical,Spine and ENT physicianswith a comprehensive suite ofproducts developed for the finetolerances required by thesespecialties. Continued productinnovation allows these specialtycare providers to improve theirexisting surgical procedures,while exploring new techniquesto further advance the clinicaloutcomes of their patients.Products include electric andpneumatic drill systems andaccessories, an ultrasonicaspiration device for soft tissueremoval, non-stick bipolarforceps, bone mill, and biofragmentable nasal dressings.Customized Cranial ImplantsCustomized Cranial Implantsare designed in collaborationwith the surgeon for individualpatient care, to restore normalform and function to thecraniofacial bone. Stryker isthe only company to offer achoice of PMMA, PEEK, andMEDPOR material types.Financial and market information reflects 2014 MarketShare 1.1B#222%Stryker is a market leader inproducts used in maxillofacial,craniofacial and neurosurgicalprocedures. Its comprehensiveproduct portfolio is designedto provide innovative solutionsto healthcare providerswith the goal of improvedsurgical outcomes. Thecraniomaxillofacial productline features bone fixationsystems, biomaterials, porouspolyethylene implants,microdissection needles andsurgical instrumentation toaddress a wide variety of surgicalspecialties and procedures.AccuLIFThe AccuLIF expandablelumbar interbody technologyoffers surgeons the ability toinsert an interbody device ata smaller starting height andis the first steerable curvedexpandable TLIF device on theUS market.**Data on file at Stryker Spine.SPINEMarketSizeMarketPositionMarketShare 9.0B#48%SPINAL IMPLANTSStryker offers one of the most comprehensive and diverse productportfolios for the treatment of degenerative and complex spinaldisorders. The Company is committed to developing technologiesfor traditional and minimally invasive surgical techniques,enabling surgeons to help their patients return to a more activelifestyle. Products include implants, instruments and biologicssolutions for the cervical, thoracic and lumbar spine.INTERVENTIONAL SPINEThe Interventional Spine business provides a single source forearly, minimally invasive solutions to treat back pain and helpreturn patients to their active lives. It provides an extensiveand innovative product portfolio for vertebral augmentation,vertebroplasty and radiofrequency ablation procedures, along witha diagnostic tool and decompression treatment fordisc herniations.ES2ES2 is a minimally invasivefixation system focused onproviding efficiency, simplicityand security. The systemfeatures a one-piece lowprofile Integrated Blade Screwwith built in reduction andstreamlined instrumentation,and is compatible withStryker’s Navigation and Powertechnologies.SonopetThe Sonopet ultrasonicaspirator provides exceptionalcontrol of soft tissue dissectionin close proximity to delicateanatomic structures. Byaddressing multiple userneeds, it aids in consolidatingOR equipment and providesthe user with a customizedexperience.Vertebral AugmentationSystemWith the addition of the11G iVAS system, TroflexCurved Needle and 11GCurette, IVS offers oneof the most complete andleast invasive vertebralaugmentation systems onthe market.

M & A TO ENHANCE PORTFOLIOAscentPorexOtisMedCoAlignInnovations, Inc.PivotTrauson MedicalConcentricOrthovita2009Core lSurpass2013Patient SafetyTechnologiesCHG HospitalBeds2014MAKONeurovascular72015Small BoneInnovationsBerchtoldHoldingRECENT ACQUISITION HIGHLIGHTSMAKOSURGICAL CORP.PIVOTMEDICAL, INC.PATIENT SAFETYTECHNOLOGIES, INC.BERCHTOLDHOLDING, AGSMALL BONECHGINNOVATIONS, INC. (SBi) HOSPITAL BEDS, INC.MAKO has establisheda compelling technologyplatform in robotic armassisted surgery which Strykerbelieves has considerablelong-term potential in jointreconstruction. The acquisitionof MAKO combined withStryker’s strong history injoint reconstruction, capitalequipment (operating roomintegration and surgicalnavigation) and surgicalinstruments will help furtheradvance the growth of roboticarm assisted surgery. Itscombined expertise offersthe potential to simplify jointreconstruction procedures,reduce variability andenhance the surgeon andpatient experience.Pivot has a platform ofinnovative instruments andimplants, with a focus onhip arthroscopy procedurestreating femoroacetabularimpingement syndrome,to efficiently access andrestore the mobility of thehip with minimal incisions.Hip arthroscopy is thefastest growing procedure insports medicine as a resultof improved proceduralsolutions and growing demandfor less invasive solutions.Pivot’s innovative productscomplement Stryker’s existingsports medicine portfolio andprovide Stryker’s customerswith a comprehensive offeringto address the challenges ofSports Medicine procedures.The company’s proprietarySafety-Sponge System andSurgiCount 360 compliancesoftware help prevent RetainedForeign Objects (RFOs) inthe operating room, therebyimproving patient safety andreducing healthcare costs.RFOs are the most commonoperating room “Never Event”in the United States. Spongesare the most common retainedobject, with approximately2,300 incidents reportedannually at an average costper incident of over 400,000.The SurgiCount Safety-SpongeSystem offers a way to eliminateunnecessary costs from thehealthcare system whileimproving quality of care.Berchtold has providedcustomer-centric healthcareequipment for over 90 years.Their product portfolioincludes surgical tables,equipment booms and surgicallighting systems gearedtowards maximizing efficiencyand safety in operating roomsand ICUs. Combining thesecomplementary solutionswith Stryker Endoscopy’sexisting operating roomequipment portfolio created acomprehensive, quality-focusedoffering equipped to satisfy awide range of customer needsaround the globe.SBi products are designedand promoted for upper andlower extremity small boneindications, with a focus onsmall joint replacement. Withthe addition of the STAR Ankleto the Stryker Foot & Ankleproduct portfolio, Strykercomprehensively addresses thebroad range of foot and ankleprocedures. Additional assetsinclude finger, wrist and elbowproducts, further expandingthe existing Stryker upperextremity product offerings.CHG designs, manufacturesand markets a series of lowheight hospital beds and relatedaccessories. CHG’s beds allowa patient’s feet to sit flat on thefloor while he/she is sittingat the edge of the bed. Thelow-height design helps reducethe risk of patient falls that arerelated to entering and exitinghospital beds. Among CHG’sinnovative offerings is therecently launched Spirit Onebed, which is an expandablelow-height bariatric bed for theacute care segment.

FINANCIAL SUMMARY8( IN MILLIONS, EXCEPT PER SHARE AMOUNTS)CONSOLIDATED OPERATIONSNet salesCost of salesGross profitR&DSG&A% OF SALESYR/YR CHANGE20122013201420122013201420122013 8,657 9,021 .8%12.2%36.2%3,3673,4923,57539%39%37%Recall charges, net of insurance recoveries1746227612%7%8%Intangibles 0.8%)22.2%95.5%Total operating expensesOperating incomeOther income (expense)Earnings before income taxesIncome eported net djusted net earnings 1,648 1,714 1,81019%19%19%7.3%4.0%5.6%DILUTED PER SHARE AMOUNTSRECONCILIATION OF GAAP TONON-GAAP RESULTSReported Net Earnings201220132014201220132014 1.34 1,298 1,006 515 3.39 2.63Acquisition and integration related charges3772650.090.190.17Amortization of intangible assets88981330.230.260.350.20Restructuring and related charges5946780.150.12Regulatory and legal te and other recall mattersDonation-15--0.04-Tax matters-(46)391-(0.12)1.02 1,648 1,714 1,810 4.30 4.49 4.73Adjusted Net Earnings

( IN MILLIONS)FINANCIALSUMMARYCONDENSED BALANCE SHEETS201220132014AssetsCash and cash equivalents 1,395 1,339 1,795Marketable securities2,8902,6413,205Accounts receivable r current assets1,1681,4151,5138,1488,3359,673Property, plant and equipment (net)9481,0811,098Goodwill and other intangibles (net)3,5665,8336,204544494738 13,206 15,743 17,713 1,876 2,657 4,4649871,3001,408Long-term debt, excluding current maturities1,7462,7393,246Shareholders' equity8,5979,0478,595Total liabilities and shareholders' equity 13,206 15,743 17,713CONDENSED STATEMENTS OF CASH FLOW201220132014Net earnings 1,298 1,006 515Depreciation154169190Intangibles itions, net of cash acquired(154)(2,320)(916)Change in marketable securities, net(372)298(729)Purchases of property, plant and equipment(210)(195)(233)(736)(2,217)(1,878)Total current assets( IN MILLIONS)Other assetsCAPITAL ALLOCATION2012201320143 YEARTOTALMergers & acquisitions1 154 2,320 916 3,390Dividends3244014621,187Share repurchases108317100525 586 3,038 1,478 5,102Total9Total assetsLiabilities and shareholders' equityCurrent liabilitiesOther liabilities1Net of cash acquiredOperating activitiesChanges in operating assets and liabilities and other, netNet cash provided by operating activitiesInvesting activitiesNet cash used in investing activitiesFinancing activities(Payments of) proceeds from borrowings, netDividends paidRepurchase and retirement of common stockOtherNet cash (used in) provided by financing activitiesEffect of exchange rate changes on cash and cash equivalentsChange in cash and cash 100)(13)1332(449)30062918(25)(77) 490( 56) 456

ADDITIONAL INFORMATIONEXECUTIVE LEADERSHIP TEAMKEVIN A. LOBOChairman and Chief Executive OfficerYIN C. BECKERVice President, Communications,Public Affairs and Strategic MarketingM. KATHRYN FINKVice President, Chief Human ResourcesOfficer, Global Human ResourcesDAVID K. FLOYDGroup President, OrthopaedicsGLENN S. BOEHNLEINVice President, Chief Financial OfficerMICHAEL D. HUTCHINSONGeneral CounselLONNY J. CARPENTERGroup President, Global Qualityand Business OperationsKATHERINE A. OWENVice President, Strategy and InvestorRelationsBIJOY S. N. SAGARVice President, Chief Information OfficerTIMOTHY J. SCANNELLGroup President, MedSurg andNeurotechnologyTRANSFER AGENT AND REGISTRARAmerican Stock Transfer &Trust Company, LLCNew York, New YorkShareholders needing information regardingtheir certificates or dividends should contact:American Stock Transfer &Trust Company, LLCOperations Center6201 15th Avenue, New York, NY 11219800 937 5449 info@amstock.comOTHER OFFICERSDEAN H. BERGYVice President, Corporate SecretaryDAVID G. FURGASONVice President, TaxWILLIAM E. BERRY, JR.Vice President, Corporate ControllerELIZABETH A. STAUBVice President, Regulatory Affairsand Quality AssuranceJEANNE M. BLONDIAVice President, Finance and TreasurerIRENE B. CORBEVice President, Internal AuditBRONWEN R. TAYLORVice President, Compliance andRisk ManagementSTOCK LISTINGThe Company’s common stock is traded onthe New York Stock Exchange under the symbol SYK.DIVISION PRESIDENTSBusinessesRegionsWILLIAM J. HUFFNAGLEReconstructiveBRADFORD L. SAARMedicalMAURICE BEN-MAYORSouth PacificGRAHAM A. MCLEANJapanXAVIER BERLINGTrauma & ExtremitiesSPENCER S. STILESInstrumentsSTUART SILKEuropeSCOTT MACNAIRCanadaBRADLEY W. PADDOCKSpineBRIAN J. WHITESustainability SolutionsLAURENCE F.I. HIPKINEastern Europe, Middle East,AfricaM. BRENT SCOTTAsiaMARK H. PAULNeurovascularINDEPENDENT REGISTEREDPUBLIC ACCOUNTING FIRMErnst & Young LLPGrand Rapids, MichiganFABRIZIO SIGNORINLatin AmericaJ. ANDREW PIERCEEndoscopyStryker Corporation or its divisions or other corporate affiliated entities own, use or have applied for the following trademarks or service marks:Accolade, AccuLIF, ES2, Exeter, Hoffmann, ICONIX, Isolibrium, iVAS, MAKOplasty, MAKO Surgical Corp., MEDPOR, Memometal, NAV3i, Neptune,OtisMed, ReUnion, RIO, SDC3, Simplex, Small Bone Innovations, SmartLock, SOMA, Sonopet, STAR, Stryker, Stryker Orthopaedics, Target,Trevo, Triathlon, Tritanium, Troflex, X3. All other trademarks are trademarks of their respective owners or holders.

Neptune Waste Management System Market-leading waste management system provides improved OR efficiency and protection to both the patient and caregiver from hazardous fluid waste. ICONIX ICONIX is an all-suture anchor system used to repair soft tissue sports injuries throughout the body and includes a proprietary curved delivery system that .